Analyst firms · Morgan Stanley · TFX

Morgan Stanley TFX price target and rating history

Teleflex Incorporated (TFX) · Health Care

Morgan Stanley rates Teleflex Incorporated (TFX) Overweight with a $261 price target, as of its latest action on Dec 4, 2023. It has published 5 rating actions on TFX since October 2021, including 1 upgrade and 1 downgrade. Across 7 firms with a TFX price target in the last 12 months, the median target is $155.

Current rating
Overweight
Price target
$261
Median target, all firms
$155
Actions on TFX
5

Morgan Stanley price target on TFX

$431$346$26120222023202420252026
Morgan Stanley price target on TFX, each point a stated target, October 2021 to December 2023.

Every Morgan Stanley rating on TFX

How other firms rate TFX

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
BofA SecuritiesBuy$158Sep 28, 2026
UBSNeutral$145Jul 28, 2026
BMO Capital MarketsOutperform$159Jul 9, 2026
Piper SandlerOverweight$160Jun 8, 2026
RBC Capital MarketsOutperform$155May 8, 2026
Raymond JamesOutperform$128Mar 27, 2026
NeedhamBuy$138Jan 27, 2026

Questions about Morgan Stanley and TFX

What is Morgan Stanley's price target for TFX?
Morgan Stanley's latest stated price target for Teleflex Incorporated (TFX) is $261, from its action on Dec 4, 2023.
What is Morgan Stanley's rating on TFX?
Morgan Stanley rates TFX Overweight, a bullish rating, as of Dec 4, 2023.
When did Morgan Stanley last change its view on TFX?
On Dec 4, 2023, Morgan Stanley upgrades to Overweight from Equal-Weight, price target $261.
How does Morgan Stanley's TFX target compare with other analysts?
Across 7 firms with a TFX price target in the last 12 months, the median target is $155.

More TFX rating histories

All Morgan Stanley ratingsTFX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.